nodes	percent_of_prediction	percent_of_DWPC	metapath
Arformoterol—CYP2C9—Estropipate—osteoporosis	0.118	0.284	CbGbCtD
Arformoterol—CYP2C19—Cholecalciferol—osteoporosis	0.073	0.176	CbGbCtD
Arformoterol—CYP2C9—Cholecalciferol—osteoporosis	0.0607	0.146	CbGbCtD
Arformoterol—CYP2C19—Estradiol—osteoporosis	0.0588	0.142	CbGbCtD
Arformoterol—CYP2D6—Cholecalciferol—osteoporosis	0.0555	0.134	CbGbCtD
Arformoterol—CYP2C9—Estradiol—osteoporosis	0.0489	0.118	CbGbCtD
Arformoterol—Dobutamine—CA2—osteoporosis	0.00398	1	CrCbGaD
Arformoterol—Cough—Zoledronate—osteoporosis	0.000379	0.000652	CcSEcCtD
Arformoterol—Oedema peripheral—Estradiol—osteoporosis	0.000379	0.000652	CcSEcCtD
Arformoterol—Tachycardia—Pamidronate—osteoporosis	0.000379	0.000652	CcSEcCtD
Arformoterol—Connective tissue disorder—Estradiol—osteoporosis	0.000378	0.00065	CcSEcCtD
Arformoterol—Urethral disorder—Estradiol—osteoporosis	0.000377	0.000649	CcSEcCtD
Arformoterol—Rash—Etidronic acid—osteoporosis	0.000376	0.000648	CcSEcCtD
Arformoterol—Dermatitis—Etidronic acid—osteoporosis	0.000376	0.000647	CcSEcCtD
Arformoterol—Hypertension—Zoledronate—osteoporosis	0.000375	0.000645	CcSEcCtD
Arformoterol—Hypersensitivity—Alendronate—osteoporosis	0.000375	0.000645	CcSEcCtD
Arformoterol—Headache—Etidronic acid—osteoporosis	0.000374	0.000644	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000372	0.00064	CcSEcCtD
Arformoterol—Asthenia—Estropipate—osteoporosis	0.000371	0.000638	CcSEcCtD
Arformoterol—Visual impairment—Estradiol—osteoporosis	0.00037	0.000638	CcSEcCtD
Arformoterol—Chest pain—Zoledronate—osteoporosis	0.00037	0.000636	CcSEcCtD
Arformoterol—Myalgia—Zoledronate—osteoporosis	0.00037	0.000636	CcSEcCtD
Arformoterol—Arthralgia—Zoledronate—osteoporosis	0.00037	0.000636	CcSEcCtD
Arformoterol—Palpitations—Conjugated Estrogens—osteoporosis	0.00037	0.000636	CcSEcCtD
Arformoterol—Insomnia—Risedronate—osteoporosis	0.000369	0.000636	CcSEcCtD
Arformoterol—Anxiety—Zoledronate—osteoporosis	0.000368	0.000634	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000367	0.000632	CcSEcCtD
Arformoterol—Pruritus—Estropipate—osteoporosis	0.000365	0.000629	CcSEcCtD
Arformoterol—Discomfort—Zoledronate—osteoporosis	0.000365	0.000629	CcSEcCtD
Arformoterol—Asthenia—Alendronate—osteoporosis	0.000365	0.000628	CcSEcCtD
Arformoterol—Hypersensitivity—Ibandronate—osteoporosis	0.000365	0.000628	CcSEcCtD
Arformoterol—Cough—Conjugated Estrogens—osteoporosis	0.000365	0.000628	CcSEcCtD
Arformoterol—Dyspnoea—Risedronate—osteoporosis	0.000364	0.000626	CcSEcCtD
Arformoterol—Hypotension—Pamidronate—osteoporosis	0.000363	0.000624	CcSEcCtD
Arformoterol—Dry mouth—Zoledronate—osteoporosis	0.000362	0.000622	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000361	0.000622	CcSEcCtD
Arformoterol—Fatigue—Ethinyl Estradiol—osteoporosis	0.000361	0.000621	CcSEcCtD
Arformoterol—Pruritus—Alendronate—osteoporosis	0.00036	0.00062	CcSEcCtD
Arformoterol—Dyspepsia—Risedronate—osteoporosis	0.000359	0.000619	CcSEcCtD
Arformoterol—Constipation—Ethinyl Estradiol—osteoporosis	0.000358	0.000616	CcSEcCtD
Arformoterol—Hypersensitivity—Calcitriol—osteoporosis	0.000357	0.000615	CcSEcCtD
Arformoterol—Cardiac disorder—Estradiol—osteoporosis	0.000357	0.000614	CcSEcCtD
Arformoterol—Chest pain—Conjugated Estrogens—osteoporosis	0.000356	0.000613	CcSEcCtD
Arformoterol—Arthralgia—Conjugated Estrogens—osteoporosis	0.000356	0.000613	CcSEcCtD
Arformoterol—Myalgia—Conjugated Estrogens—osteoporosis	0.000356	0.000613	CcSEcCtD
Arformoterol—Asthenia—Ibandronate—osteoporosis	0.000355	0.000612	CcSEcCtD
Arformoterol—Anxiety—Conjugated Estrogens—osteoporosis	0.000355	0.000611	CcSEcCtD
Arformoterol—Nausea—Etidronic acid—osteoporosis	0.000355	0.00061	CcSEcCtD
Arformoterol—Oedema—Zoledronate—osteoporosis	0.000354	0.00061	CcSEcCtD
Arformoterol—Anaphylactic shock—Zoledronate—osteoporosis	0.000354	0.00061	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000354	0.000609	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000354	0.000609	CcSEcCtD
Arformoterol—Diarrhoea—Estropipate—osteoporosis	0.000353	0.000608	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Risedronate—osteoporosis	0.000352	0.000607	CcSEcCtD
Arformoterol—Infection—Zoledronate—osteoporosis	0.000352	0.000606	CcSEcCtD
Arformoterol—Fatigue—Risedronate—osteoporosis	0.000352	0.000606	CcSEcCtD
Arformoterol—Insomnia—Pamidronate—osteoporosis	0.000351	0.000604	CcSEcCtD
Arformoterol—Pruritus—Ibandronate—osteoporosis	0.00035	0.000603	CcSEcCtD
Arformoterol—Pain—Risedronate—osteoporosis	0.000349	0.000601	CcSEcCtD
Arformoterol—Constipation—Risedronate—osteoporosis	0.000349	0.000601	CcSEcCtD
Arformoterol—Diarrhoea—Alendronate—osteoporosis	0.000348	0.000599	CcSEcCtD
Arformoterol—Asthenia—Calcitriol—osteoporosis	0.000348	0.000599	CcSEcCtD
Arformoterol—Nervous system disorder—Zoledronate—osteoporosis	0.000348	0.000598	CcSEcCtD
Arformoterol—Immune system disorder—Estradiol—osteoporosis	0.000347	0.000598	CcSEcCtD
Arformoterol—Mediastinal disorder—Estradiol—osteoporosis	0.000346	0.000596	CcSEcCtD
Arformoterol—Dyspnoea—Pamidronate—osteoporosis	0.000346	0.000595	CcSEcCtD
Arformoterol—Tachycardia—Zoledronate—osteoporosis	0.000346	0.000595	CcSEcCtD
Arformoterol—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000345	0.000594	CcSEcCtD
Arformoterol—Somnolence—Pamidronate—osteoporosis	0.000345	0.000594	CcSEcCtD
Arformoterol—Skin disorder—Zoledronate—osteoporosis	0.000344	0.000593	CcSEcCtD
Arformoterol—Pruritus—Calcitriol—osteoporosis	0.000343	0.00059	CcSEcCtD
Arformoterol—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000342	0.000589	CcSEcCtD
Arformoterol—Diarrhoea—Raloxifene—osteoporosis	0.000342	0.000589	CcSEcCtD
Arformoterol—Dyspepsia—Pamidronate—osteoporosis	0.000342	0.000588	CcSEcCtD
Arformoterol—Dizziness—Estropipate—osteoporosis	0.000342	0.000588	CcSEcCtD
Arformoterol—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000341	0.000587	CcSEcCtD
Arformoterol—Oedema—Conjugated Estrogens—osteoporosis	0.000341	0.000587	CcSEcCtD
Arformoterol—Infection—Conjugated Estrogens—osteoporosis	0.000339	0.000584	CcSEcCtD
Arformoterol—Diarrhoea—Ibandronate—osteoporosis	0.000339	0.000583	CcSEcCtD
Arformoterol—Mental disorder—Estradiol—osteoporosis	0.000337	0.00058	CcSEcCtD
Arformoterol—Dizziness—Alendronate—osteoporosis	0.000336	0.000579	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000335	0.000577	CcSEcCtD
Arformoterol—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000335	0.000576	CcSEcCtD
Arformoterol—Malnutrition—Estradiol—osteoporosis	0.000335	0.000576	CcSEcCtD
Arformoterol—Fatigue—Pamidronate—osteoporosis	0.000335	0.000576	CcSEcCtD
Arformoterol—Gastrointestinal pain—Risedronate—osteoporosis	0.000334	0.000575	CcSEcCtD
Arformoterol—Tachycardia—Conjugated Estrogens—osteoporosis	0.000333	0.000573	CcSEcCtD
Arformoterol—Urticaria—Ethinyl Estradiol—osteoporosis	0.000333	0.000573	CcSEcCtD
Arformoterol—Constipation—Pamidronate—osteoporosis	0.000332	0.000571	CcSEcCtD
Arformoterol—Pain—Pamidronate—osteoporosis	0.000332	0.000571	CcSEcCtD
Arformoterol—Diarrhoea—Calcitriol—osteoporosis	0.000332	0.000571	CcSEcCtD
Arformoterol—Skin disorder—Conjugated Estrogens—osteoporosis	0.000331	0.000571	CcSEcCtD
Arformoterol—Hypotension—Zoledronate—osteoporosis	0.000331	0.00057	CcSEcCtD
Arformoterol—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000331	0.00057	CcSEcCtD
Arformoterol—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000331	0.00057	CcSEcCtD
Arformoterol—Dizziness—Raloxifene—osteoporosis	0.000331	0.00057	CcSEcCtD
Arformoterol—Tension—Estradiol—osteoporosis	0.000328	0.000565	CcSEcCtD
Arformoterol—Vomiting—Estropipate—osteoporosis	0.000328	0.000565	CcSEcCtD
Arformoterol—Dysgeusia—Estradiol—osteoporosis	0.000328	0.000564	CcSEcCtD
Arformoterol—Dizziness—Ibandronate—osteoporosis	0.000328	0.000564	CcSEcCtD
Arformoterol—Rash—Estropipate—osteoporosis	0.000326	0.000561	CcSEcCtD
Arformoterol—Dermatitis—Estropipate—osteoporosis	0.000325	0.00056	CcSEcCtD
Arformoterol—Nervousness—Estradiol—osteoporosis	0.000325	0.00056	CcSEcCtD
Arformoterol—Urticaria—Risedronate—osteoporosis	0.000324	0.000558	CcSEcCtD
Arformoterol—Back pain—Estradiol—osteoporosis	0.000324	0.000557	CcSEcCtD
Arformoterol—Headache—Estropipate—osteoporosis	0.000324	0.000557	CcSEcCtD
Arformoterol—Vomiting—Alendronate—osteoporosis	0.000323	0.000557	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000323	0.000556	CcSEcCtD
Arformoterol—Abdominal pain—Risedronate—osteoporosis	0.000323	0.000555	CcSEcCtD
Arformoterol—Body temperature increased—Risedronate—osteoporosis	0.000323	0.000555	CcSEcCtD
Arformoterol—Muscle spasms—Estradiol—osteoporosis	0.000322	0.000554	CcSEcCtD
Arformoterol—Rash—Alendronate—osteoporosis	0.000321	0.000552	CcSEcCtD
Arformoterol—Insomnia—Zoledronate—osteoporosis	0.000321	0.000552	CcSEcCtD
Arformoterol—Dermatitis—Alendronate—osteoporosis	0.00032	0.000552	CcSEcCtD
Arformoterol—Feeling abnormal—Pamidronate—osteoporosis	0.00032	0.00055	CcSEcCtD
Arformoterol—Hypotension—Conjugated Estrogens—osteoporosis	0.000319	0.000549	CcSEcCtD
Arformoterol—Headache—Alendronate—osteoporosis	0.000319	0.000549	CcSEcCtD
Arformoterol—Vomiting—Raloxifene—osteoporosis	0.000318	0.000548	CcSEcCtD
Arformoterol—Gastrointestinal pain—Pamidronate—osteoporosis	0.000317	0.000546	CcSEcCtD
Arformoterol—Dyspnoea—Zoledronate—osteoporosis	0.000316	0.000544	CcSEcCtD
Arformoterol—Rash—Raloxifene—osteoporosis	0.000315	0.000543	CcSEcCtD
Arformoterol—Dermatitis—Raloxifene—osteoporosis	0.000315	0.000543	CcSEcCtD
Arformoterol—Somnolence—Zoledronate—osteoporosis	0.000315	0.000542	CcSEcCtD
Arformoterol—Vomiting—Ibandronate—osteoporosis	0.000315	0.000542	CcSEcCtD
Arformoterol—Tremor—Estradiol—osteoporosis	0.000314	0.00054	CcSEcCtD
Arformoterol—Headache—Raloxifene—osteoporosis	0.000313	0.00054	CcSEcCtD
Arformoterol—Rash—Ibandronate—osteoporosis	0.000312	0.000538	CcSEcCtD
Arformoterol—Dermatitis—Ibandronate—osteoporosis	0.000312	0.000537	CcSEcCtD
Arformoterol—Dyspepsia—Zoledronate—osteoporosis	0.000312	0.000537	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000311	0.000535	CcSEcCtD
Arformoterol—Ill-defined disorder—Estradiol—osteoporosis	0.000311	0.000535	CcSEcCtD
Arformoterol—Headache—Ibandronate—osteoporosis	0.00031	0.000534	CcSEcCtD
Arformoterol—Insomnia—Conjugated Estrogens—osteoporosis	0.000309	0.000531	CcSEcCtD
Arformoterol—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000308	0.000531	CcSEcCtD
Arformoterol—Vomiting—Calcitriol—osteoporosis	0.000308	0.000531	CcSEcCtD
Arformoterol—Agitation—Estradiol—osteoporosis	0.000308	0.000529	CcSEcCtD
Arformoterol—Nausea—Estropipate—osteoporosis	0.000307	0.000528	CcSEcCtD
Arformoterol—Abdominal pain—Pamidronate—osteoporosis	0.000307	0.000528	CcSEcCtD
Arformoterol—Body temperature increased—Pamidronate—osteoporosis	0.000307	0.000528	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000306	0.000527	CcSEcCtD
Arformoterol—Angioedema—Estradiol—osteoporosis	0.000306	0.000526	CcSEcCtD
Arformoterol—Rash—Calcitriol—osteoporosis	0.000306	0.000526	CcSEcCtD
Arformoterol—Fatigue—Zoledronate—osteoporosis	0.000306	0.000526	CcSEcCtD
Arformoterol—Dermatitis—Calcitriol—osteoporosis	0.000305	0.000526	CcSEcCtD
Arformoterol—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000304	0.000524	CcSEcCtD
Arformoterol—Headache—Calcitriol—osteoporosis	0.000304	0.000523	CcSEcCtD
Arformoterol—Somnolence—Conjugated Estrogens—osteoporosis	0.000303	0.000522	CcSEcCtD
Arformoterol—Constipation—Zoledronate—osteoporosis	0.000303	0.000522	CcSEcCtD
Arformoterol—Pain—Zoledronate—osteoporosis	0.000303	0.000522	CcSEcCtD
Arformoterol—Nausea—Alendronate—osteoporosis	0.000302	0.00052	CcSEcCtD
Arformoterol—Malaise—Estradiol—osteoporosis	0.000302	0.00052	CcSEcCtD
Arformoterol—Hypersensitivity—Risedronate—osteoporosis	0.000301	0.000518	CcSEcCtD
Arformoterol—Dyspepsia—Conjugated Estrogens—osteoporosis	0.0003	0.000517	CcSEcCtD
Arformoterol—Asthenia—Ethinyl Estradiol—osteoporosis	0.0003	0.000517	CcSEcCtD
Arformoterol—Nausea—Raloxifene—osteoporosis	0.000297	0.000512	CcSEcCtD
Arformoterol—Pruritus—Ethinyl Estradiol—osteoporosis	0.000296	0.00051	CcSEcCtD
Arformoterol—Palpitations—Estradiol—osteoporosis	0.000296	0.000509	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000295	0.000507	CcSEcCtD
Arformoterol—Fatigue—Conjugated Estrogens—osteoporosis	0.000294	0.000506	CcSEcCtD
Arformoterol—Nausea—Ibandronate—osteoporosis	0.000294	0.000506	CcSEcCtD
Arformoterol—Asthenia—Risedronate—osteoporosis	0.000293	0.000504	CcSEcCtD
Arformoterol—Feeling abnormal—Zoledronate—osteoporosis	0.000292	0.000503	CcSEcCtD
Arformoterol—Cough—Estradiol—osteoporosis	0.000292	0.000503	CcSEcCtD
Arformoterol—Constipation—Conjugated Estrogens—osteoporosis	0.000292	0.000502	CcSEcCtD
Arformoterol—Pain—Conjugated Estrogens—osteoporosis	0.000292	0.000502	CcSEcCtD
Arformoterol—Gastrointestinal pain—Zoledronate—osteoporosis	0.00029	0.000499	CcSEcCtD
Arformoterol—Hypertension—Estradiol—osteoporosis	0.000289	0.000497	CcSEcCtD
Arformoterol—Pruritus—Risedronate—osteoporosis	0.000289	0.000497	CcSEcCtD
Arformoterol—Nausea—Calcitriol—osteoporosis	0.000288	0.000496	CcSEcCtD
Arformoterol—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000286	0.000493	CcSEcCtD
Arformoterol—Hypersensitivity—Pamidronate—osteoporosis	0.000286	0.000492	CcSEcCtD
Arformoterol—Arthralgia—Estradiol—osteoporosis	0.000285	0.00049	CcSEcCtD
Arformoterol—Myalgia—Estradiol—osteoporosis	0.000285	0.00049	CcSEcCtD
Arformoterol—Chest pain—Estradiol—osteoporosis	0.000285	0.00049	CcSEcCtD
Arformoterol—Anxiety—Estradiol—osteoporosis	0.000284	0.000489	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000283	0.000487	CcSEcCtD
Arformoterol—Urticaria—Zoledronate—osteoporosis	0.000282	0.000485	CcSEcCtD
Arformoterol—Discomfort—Estradiol—osteoporosis	0.000282	0.000485	CcSEcCtD
Arformoterol—Body temperature increased—Zoledronate—osteoporosis	0.00028	0.000482	CcSEcCtD
Arformoterol—Abdominal pain—Zoledronate—osteoporosis	0.00028	0.000482	CcSEcCtD
Arformoterol—Diarrhoea—Risedronate—osteoporosis	0.000279	0.000481	CcSEcCtD
Arformoterol—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000279	0.00048	CcSEcCtD
Arformoterol—Dry mouth—Estradiol—osteoporosis	0.000279	0.00048	CcSEcCtD
Arformoterol—Asthenia—Pamidronate—osteoporosis	0.000278	0.000479	CcSEcCtD
Arformoterol—Dizziness—Ethinyl Estradiol—osteoporosis	0.000277	0.000477	CcSEcCtD
Arformoterol—Pruritus—Pamidronate—osteoporosis	0.000275	0.000473	CcSEcCtD
Arformoterol—Anaphylactic shock—Estradiol—osteoporosis	0.000273	0.00047	CcSEcCtD
Arformoterol—Oedema—Estradiol—osteoporosis	0.000273	0.00047	CcSEcCtD
Arformoterol—Infection—Estradiol—osteoporosis	0.000271	0.000467	CcSEcCtD
Arformoterol—Urticaria—Conjugated Estrogens—osteoporosis	0.000271	0.000467	CcSEcCtD
Arformoterol—Dizziness—Risedronate—osteoporosis	0.00027	0.000465	CcSEcCtD
Arformoterol—Abdominal pain—Conjugated Estrogens—osteoporosis	0.00027	0.000464	CcSEcCtD
Arformoterol—Body temperature increased—Conjugated Estrogens—osteoporosis	0.00027	0.000464	CcSEcCtD
Arformoterol—Nervous system disorder—Estradiol—osteoporosis	0.000268	0.000461	CcSEcCtD
Arformoterol—Tachycardia—Estradiol—osteoporosis	0.000267	0.000459	CcSEcCtD
Arformoterol—Vomiting—Ethinyl Estradiol—osteoporosis	0.000266	0.000458	CcSEcCtD
Arformoterol—Diarrhoea—Pamidronate—osteoporosis	0.000265	0.000457	CcSEcCtD
Arformoterol—Skin disorder—Estradiol—osteoporosis	0.000265	0.000457	CcSEcCtD
Arformoterol—Rash—Ethinyl Estradiol—osteoporosis	0.000264	0.000454	CcSEcCtD
Arformoterol—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000264	0.000454	CcSEcCtD
Arformoterol—Headache—Ethinyl Estradiol—osteoporosis	0.000262	0.000451	CcSEcCtD
Arformoterol—Hypersensitivity—Zoledronate—osteoporosis	0.000261	0.00045	CcSEcCtD
Arformoterol—Vomiting—Risedronate—osteoporosis	0.00026	0.000447	CcSEcCtD
Arformoterol—Rash—Risedronate—osteoporosis	0.000257	0.000443	CcSEcCtD
Arformoterol—Dermatitis—Risedronate—osteoporosis	0.000257	0.000443	CcSEcCtD
Arformoterol—Dizziness—Pamidronate—osteoporosis	0.000257	0.000442	CcSEcCtD
Arformoterol—Headache—Risedronate—osteoporosis	0.000256	0.00044	CcSEcCtD
Arformoterol—Asthenia—Zoledronate—osteoporosis	0.000254	0.000438	CcSEcCtD
Arformoterol—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000251	0.000433	CcSEcCtD
Arformoterol—Pruritus—Zoledronate—osteoporosis	0.000251	0.000432	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000249	0.000428	CcSEcCtD
Arformoterol—Nausea—Ethinyl Estradiol—osteoporosis	0.000249	0.000428	CcSEcCtD
Arformoterol—Insomnia—Estradiol—osteoporosis	0.000247	0.000425	CcSEcCtD
Arformoterol—Vomiting—Pamidronate—osteoporosis	0.000247	0.000425	CcSEcCtD
Arformoterol—Asthenia—Conjugated Estrogens—osteoporosis	0.000245	0.000422	CcSEcCtD
Arformoterol—Rash—Pamidronate—osteoporosis	0.000245	0.000421	CcSEcCtD
Arformoterol—Dermatitis—Pamidronate—osteoporosis	0.000244	0.000421	CcSEcCtD
Arformoterol—Dyspnoea—Estradiol—osteoporosis	0.000244	0.000419	CcSEcCtD
Arformoterol—Headache—Pamidronate—osteoporosis	0.000243	0.000418	CcSEcCtD
Arformoterol—Somnolence—Estradiol—osteoporosis	0.000243	0.000418	CcSEcCtD
Arformoterol—Diarrhoea—Zoledronate—osteoporosis	0.000243	0.000417	CcSEcCtD
Arformoterol—Nausea—Risedronate—osteoporosis	0.000242	0.000417	CcSEcCtD
Arformoterol—Pruritus—Conjugated Estrogens—osteoporosis	0.000241	0.000416	CcSEcCtD
Arformoterol—Dyspepsia—Estradiol—osteoporosis	0.00024	0.000414	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Estradiol—osteoporosis	0.000236	0.000406	CcSEcCtD
Arformoterol—Fatigue—Estradiol—osteoporosis	0.000235	0.000405	CcSEcCtD
Arformoterol—Dizziness—Zoledronate—osteoporosis	0.000234	0.000403	CcSEcCtD
Arformoterol—Pain—Estradiol—osteoporosis	0.000234	0.000402	CcSEcCtD
Arformoterol—Constipation—Estradiol—osteoporosis	0.000234	0.000402	CcSEcCtD
Arformoterol—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000234	0.000402	CcSEcCtD
Arformoterol—Nausea—Pamidronate—osteoporosis	0.00023	0.000397	CcSEcCtD
Arformoterol—Dizziness—Conjugated Estrogens—osteoporosis	0.000226	0.000388	CcSEcCtD
Arformoterol—Vomiting—Zoledronate—osteoporosis	0.000225	0.000388	CcSEcCtD
Arformoterol—Feeling abnormal—Estradiol—osteoporosis	0.000225	0.000387	CcSEcCtD
Arformoterol—Rash—Zoledronate—osteoporosis	0.000223	0.000385	CcSEcCtD
Arformoterol—Gastrointestinal pain—Estradiol—osteoporosis	0.000223	0.000384	CcSEcCtD
Arformoterol—Dermatitis—Zoledronate—osteoporosis	0.000223	0.000384	CcSEcCtD
Arformoterol—Headache—Zoledronate—osteoporosis	0.000222	0.000382	CcSEcCtD
Arformoterol—Vomiting—Conjugated Estrogens—osteoporosis	0.000217	0.000374	CcSEcCtD
Arformoterol—Urticaria—Estradiol—osteoporosis	0.000217	0.000374	CcSEcCtD
Arformoterol—Abdominal pain—Estradiol—osteoporosis	0.000216	0.000372	CcSEcCtD
Arformoterol—Body temperature increased—Estradiol—osteoporosis	0.000216	0.000372	CcSEcCtD
Arformoterol—Rash—Conjugated Estrogens—osteoporosis	0.000215	0.00037	CcSEcCtD
Arformoterol—Dermatitis—Conjugated Estrogens—osteoporosis	0.000215	0.00037	CcSEcCtD
Arformoterol—Headache—Conjugated Estrogens—osteoporosis	0.000214	0.000368	CcSEcCtD
Arformoterol—Nausea—Zoledronate—osteoporosis	0.000211	0.000362	CcSEcCtD
Arformoterol—Nausea—Conjugated Estrogens—osteoporosis	0.000203	0.000349	CcSEcCtD
Arformoterol—Hypersensitivity—Estradiol—osteoporosis	0.000201	0.000346	CcSEcCtD
Arformoterol—Asthenia—Estradiol—osteoporosis	0.000196	0.000337	CcSEcCtD
Arformoterol—Pruritus—Estradiol—osteoporosis	0.000193	0.000333	CcSEcCtD
Arformoterol—Diarrhoea—Estradiol—osteoporosis	0.000187	0.000322	CcSEcCtD
Arformoterol—Dizziness—Estradiol—osteoporosis	0.000181	0.000311	CcSEcCtD
Arformoterol—Vomiting—Estradiol—osteoporosis	0.000174	0.000299	CcSEcCtD
Arformoterol—Rash—Estradiol—osteoporosis	0.000172	0.000296	CcSEcCtD
Arformoterol—Dermatitis—Estradiol—osteoporosis	0.000172	0.000296	CcSEcCtD
Arformoterol—Headache—Estradiol—osteoporosis	0.000171	0.000295	CcSEcCtD
Arformoterol—Nausea—Estradiol—osteoporosis	0.000162	0.000279	CcSEcCtD
Arformoterol—ADRB1—GPCR ligand binding—PTH—osteoporosis	2.25e-06	0.00415	CbGpPWpGaD
Arformoterol—ADRB2—GPCR ligand binding—PTH—osteoporosis	2.2e-06	0.00406	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—CALCR—osteoporosis	2.2e-06	0.00405	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—PTH1R—osteoporosis	2.2e-06	0.00405	CbGpPWpGaD
Arformoterol—ADRB1—GPCR ligand binding—CNR2—osteoporosis	2.19e-06	0.00404	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—PTH1R—osteoporosis	2.15e-06	0.00397	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—CALCR—osteoporosis	2.15e-06	0.00397	CbGpPWpGaD
Arformoterol—ADRB2—GPCR ligand binding—CNR2—osteoporosis	2.14e-06	0.00396	CbGpPWpGaD
Arformoterol—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	2.07e-06	0.00382	CbGpPWpGaD
Arformoterol—ADRB1—GPCR ligand binding—WNT1—osteoporosis	2.06e-06	0.0038	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	2.05e-06	0.00379	CbGpPWpGaD
Arformoterol—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	2.05e-06	0.00379	CbGpPWpGaD
Arformoterol—ADRB2—GPCR ligand binding—WNT1—osteoporosis	2.01e-06	0.00372	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	1.94e-06	0.00359	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—MGLL—osteoporosis	1.92e-06	0.00355	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—MGLL—osteoporosis	1.88e-06	0.00347	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	1.87e-06	0.00345	CbGpPWpGaD
Arformoterol—ADRB1—GPCR ligand binding—PTHLH—osteoporosis	1.86e-06	0.00344	CbGpPWpGaD
Arformoterol—CYP2C19—Phase 1 - Functionalization of compounds—POMC—osteoporosis	1.82e-06	0.00337	CbGpPWpGaD
Arformoterol—ADRB2—GPCR ligand binding—PTHLH—osteoporosis	1.82e-06	0.00336	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	1.77e-06	0.00327	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—MGLL—osteoporosis	1.74e-06	0.00322	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—MGLL—osteoporosis	1.71e-06	0.00315	CbGpPWpGaD
Arformoterol—CYP2D6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	1.68e-06	0.0031	CbGpPWpGaD
Arformoterol—CYP2C9—Phase 1 - Functionalization of compounds—POMC—osteoporosis	1.66e-06	0.00307	CbGpPWpGaD
Arformoterol—ADRB1—GPCR ligand binding—CALCA—osteoporosis	1.64e-06	0.00303	CbGpPWpGaD
Arformoterol—CYP2C19—Biological oxidations—CYP19A1—osteoporosis	1.61e-06	0.00298	CbGpPWpGaD
Arformoterol—ADRB2—GPCR ligand binding—CALCA—osteoporosis	1.6e-06	0.00296	CbGpPWpGaD
Arformoterol—CYP2C19—Metapathway biotransformation—CYP19A1—osteoporosis	1.59e-06	0.00294	CbGpPWpGaD
Arformoterol—CYP2A6—Biological oxidations—POMC—osteoporosis	1.59e-06	0.00293	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	1.51e-06	0.00279	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—PKM—osteoporosis	1.5e-06	0.00277	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—FDPS—osteoporosis	1.5e-06	0.00277	CbGpPWpGaD
Arformoterol—CYP2D6—Biological oxidations—CYP19A1—osteoporosis	1.48e-06	0.00274	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	1.47e-06	0.00272	CbGpPWpGaD
Arformoterol—CYP2C9—Biological oxidations—CYP19A1—osteoporosis	1.47e-06	0.00271	CbGpPWpGaD
Arformoterol—CYP2D6—Metapathway biotransformation—CYP19A1—osteoporosis	1.46e-06	0.0027	CbGpPWpGaD
Arformoterol—CYP2C9—Metapathway biotransformation—CYP19A1—osteoporosis	1.45e-06	0.00268	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—SOST—osteoporosis	1.43e-06	0.00265	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—GPD2—osteoporosis	1.42e-06	0.00262	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—PGLS—osteoporosis	1.42e-06	0.00262	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—SOST—osteoporosis	1.4e-06	0.00259	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	1.38e-06	0.00255	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	1.34e-06	0.00248	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—ATIC—osteoporosis	1.3e-06	0.0024	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—PNP—osteoporosis	1.3e-06	0.0024	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—PTH1R—osteoporosis	1.3e-06	0.0024	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—CALCR—osteoporosis	1.3e-06	0.0024	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—PTH—osteoporosis	1.27e-06	0.00235	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PTH1R—osteoporosis	1.27e-06	0.00234	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CALCR—osteoporosis	1.27e-06	0.00234	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—PTH—osteoporosis	1.24e-06	0.00229	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—CNR2—osteoporosis	1.24e-06	0.00229	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—CNR2—osteoporosis	1.21e-06	0.00224	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	1.18e-06	0.00218	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—PTH—osteoporosis	1.15e-06	0.00213	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—PTH—osteoporosis	1.13e-06	0.00208	CbGpPWpGaD
Arformoterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	1.13e-06	0.00208	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—CNR2—osteoporosis	1.12e-06	0.00208	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—CA2—osteoporosis	1.1e-06	0.00204	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—OXCT1—osteoporosis	1.1e-06	0.00204	CbGpPWpGaD
Arformoterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	1.1e-06	0.00203	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—CNR2—osteoporosis	1.1e-06	0.00203	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—MGLL—osteoporosis	1.08e-06	0.00199	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	1.07e-06	0.00198	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—WNT1—osteoporosis	1.06e-06	0.00195	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—PTHLH—osteoporosis	1.05e-06	0.00194	CbGpPWpGaD
Arformoterol—CYP2A6—NRF2 pathway—TGFB1—osteoporosis	1.04e-06	0.00193	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—WNT1—osteoporosis	1.03e-06	0.00191	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—MGLL—osteoporosis	1.03e-06	0.0019	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—PTHLH—osteoporosis	1.03e-06	0.0019	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—MGLL—osteoporosis	1.01e-06	0.00186	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—LRP5—osteoporosis	1.01e-06	0.00186	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1e-06	0.00185	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—LRP5—osteoporosis	9.84e-07	0.00182	CbGpPWpGaD
Arformoterol—CYP2C19—Biological oxidations—POMC—osteoporosis	9.69e-07	0.00179	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—LRP6—osteoporosis	9.62e-07	0.00178	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—PTHLH—osteoporosis	9.56e-07	0.00176	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—LRP6—osteoporosis	9.41e-07	0.00174	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—PTHLH—osteoporosis	9.35e-07	0.00173	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—CALCA—osteoporosis	9.27e-07	0.00171	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—IDH2—osteoporosis	9.15e-07	0.00169	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—PKM—osteoporosis	9.14e-07	0.00169	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—FDPS—osteoporosis	9.14e-07	0.00169	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	9.14e-07	0.00169	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—CALCA—osteoporosis	9.06e-07	0.00167	CbGpPWpGaD
Arformoterol—CYP2D6—Biological oxidations—POMC—osteoporosis	8.91e-07	0.00165	CbGpPWpGaD
Arformoterol—CYP2C9—Biological oxidations—POMC—osteoporosis	8.83e-07	0.00163	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—PGLS—osteoporosis	8.66e-07	0.0016	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—GPD2—osteoporosis	8.66e-07	0.0016	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—CYP27A1—osteoporosis	8.61e-07	0.00159	CbGpPWpGaD
Arformoterol—ADRB1—GPCR ligand binding—POMC—osteoporosis	8.58e-07	0.00158	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—CALCA—osteoporosis	8.42e-07	0.00155	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PKM—osteoporosis	8.4e-07	0.00155	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—FDPS—osteoporosis	8.4e-07	0.00155	CbGpPWpGaD
Arformoterol—ADRB2—GPCR ligand binding—POMC—osteoporosis	8.39e-07	0.00155	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—ACP5—osteoporosis	8.37e-07	0.00155	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PKM—osteoporosis	8.33e-07	0.00154	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—FDPS—osteoporosis	8.33e-07	0.00154	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—CALCA—osteoporosis	8.23e-07	0.00152	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—TLN1—osteoporosis	8.12e-07	0.0015	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PGLS—osteoporosis	7.97e-07	0.00147	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—GPD2—osteoporosis	7.97e-07	0.00147	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—TLN1—osteoporosis	7.95e-07	0.00147	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—PNP—osteoporosis	7.92e-07	0.00146	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—ATIC—osteoporosis	7.92e-07	0.00146	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—GPD2—osteoporosis	7.9e-07	0.00146	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PGLS—osteoporosis	7.9e-07	0.00146	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—TPI1—osteoporosis	7.78e-07	0.00144	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—P4HB—osteoporosis	7.32e-07	0.00135	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—ATIC—osteoporosis	7.29e-07	0.00135	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PNP—osteoporosis	7.29e-07	0.00135	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PNP—osteoporosis	7.22e-07	0.00133	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—ATIC—osteoporosis	7.22e-07	0.00133	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—GAPDH—osteoporosis	7.18e-07	0.00133	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—P4HB—osteoporosis	7.01e-07	0.00129	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—RAP1A—osteoporosis	7e-07	0.00129	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—P4HB—osteoporosis	6.85e-07	0.00127	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—PTH—osteoporosis	6.81e-07	0.00126	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—OXCT1—osteoporosis	6.74e-07	0.00124	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—CA2—osteoporosis	6.74e-07	0.00124	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—RAP1A—osteoporosis	6.7e-07	0.00124	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PTH—osteoporosis	6.67e-07	0.00123	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—CNR2—osteoporosis	6.64e-07	0.00123	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—ADCY5—osteoporosis	6.59e-07	0.00122	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—MGLL—osteoporosis	6.56e-07	0.00121	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—RAP1A—osteoporosis	6.55e-07	0.00121	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—NFATC1—osteoporosis	6.53e-07	0.00121	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CNR2—osteoporosis	6.5e-07	0.0012	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—DKK1—osteoporosis	6.48e-07	0.0012	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—ADCY5—osteoporosis	6.45e-07	0.00119	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—NFATC1—osteoporosis	6.39e-07	0.00118	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—DKK1—osteoporosis	6.34e-07	0.00117	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—WNT1—osteoporosis	6.24e-07	0.00115	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—OXCT1—osteoporosis	6.2e-07	0.00114	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—CA2—osteoporosis	6.2e-07	0.00114	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	6.19e-07	0.00114	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—OXCT1—osteoporosis	6.14e-07	0.00113	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—CA2—osteoporosis	6.14e-07	0.00113	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—WNT1—osteoporosis	6.11e-07	0.00113	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—FGA—osteoporosis	6.07e-07	0.00112	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—MGLL—osteoporosis	6.04e-07	0.00111	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—ADCY5—osteoporosis	5.99e-07	0.00111	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—MGLL—osteoporosis	5.99e-07	0.00111	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—FGA—osteoporosis	5.94e-07	0.0011	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—ADCY5—osteoporosis	5.86e-07	0.00108	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—ENO1—osteoporosis	5.66e-07	0.00104	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—BMP2—osteoporosis	5.65e-07	0.00104	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—PTHLH—osteoporosis	5.65e-07	0.00104	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	5.64e-07	0.00104	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—IDH2—osteoporosis	5.58e-07	0.00103	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—PSMA2—osteoporosis	5.57e-07	0.00103	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—PSMA5—osteoporosis	5.57e-07	0.00103	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—FGB—osteoporosis	5.53e-07	0.00102	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PTHLH—osteoporosis	5.52e-07	0.00102	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—BMP2—osteoporosis	5.52e-07	0.00102	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—FGB—osteoporosis	5.41e-07	0.000998	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—PSMA2—osteoporosis	5.33e-07	0.000985	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—PSMA5—osteoporosis	5.33e-07	0.000985	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—CYP27A1—osteoporosis	5.25e-07	0.000969	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PSMA2—osteoporosis	5.22e-07	0.000963	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PSMA5—osteoporosis	5.22e-07	0.000963	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—IDH2—osteoporosis	5.13e-07	0.000948	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—ACP5—osteoporosis	5.1e-07	0.000942	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—IDH2—osteoporosis	5.09e-07	0.00094	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	5.04e-07	0.000931	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—CALCA—osteoporosis	4.97e-07	0.000918	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CALCA—osteoporosis	4.86e-07	0.000898	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—POMC—osteoporosis	4.85e-07	0.000895	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—CYP27A1—osteoporosis	4.83e-07	0.000891	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—CYP27A1—osteoporosis	4.78e-07	0.000883	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—TPI1—osteoporosis	4.75e-07	0.000876	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—POMC—osteoporosis	4.74e-07	0.000876	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—ACP5—osteoporosis	4.7e-07	0.000867	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—ACP5—osteoporosis	4.65e-07	0.000859	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	4.6e-07	0.000848	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—CYP19A1—osteoporosis	4.52e-07	0.000835	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—KL—osteoporosis	4.51e-07	0.000833	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—P4HB—osteoporosis	4.46e-07	0.000824	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—KL—osteoporosis	4.42e-07	0.000815	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—POMC—osteoporosis	4.4e-07	0.000813	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—GAPDH—osteoporosis	4.38e-07	0.000809	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—TPI1—osteoporosis	4.37e-07	0.000806	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—TPI1—osteoporosis	4.33e-07	0.000799	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—POMC—osteoporosis	4.31e-07	0.000795	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—IL6R—osteoporosis	4.29e-07	0.000793	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—RAP1A—osteoporosis	4.27e-07	0.000788	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—IL6R—osteoporosis	4.2e-07	0.000776	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—P4HB—osteoporosis	4.1e-07	0.000758	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—P4HB—osteoporosis	4.07e-07	0.000751	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—GAPDH—osteoporosis	4.03e-07	0.000744	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—GAPDH—osteoporosis	3.99e-07	0.000737	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—RAP1A—osteoporosis	3.92e-07	0.000724	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—RAP1A—osteoporosis	3.89e-07	0.000718	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.72e-07	0.000687	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—ADCY5—osteoporosis	3.69e-07	0.000682	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—GPX1—osteoporosis	3.68e-07	0.00068	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—ADCY5—osteoporosis	3.54e-07	0.000653	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—ADCY5—osteoporosis	3.46e-07	0.000639	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—ENO1—osteoporosis	3.45e-07	0.000637	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—SPP1—osteoporosis	3.42e-07	0.000632	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—PSMA2—osteoporosis	3.4e-07	0.000627	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—PSMA5—osteoporosis	3.4e-07	0.000627	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—MTHFR—osteoporosis	3.4e-07	0.000627	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.39e-07	0.000626	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—SPP1—osteoporosis	3.35e-07	0.000618	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—ENO1—osteoporosis	3.17e-07	0.000586	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—ENO1—osteoporosis	3.14e-07	0.00058	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PSMA2—osteoporosis	3.13e-07	0.000577	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PSMA5—osteoporosis	3.13e-07	0.000577	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PSMA2—osteoporosis	3.1e-07	0.000572	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PSMA5—osteoporosis	3.1e-07	0.000572	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—IRS2—osteoporosis	3.09e-07	0.000571	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—LEP—osteoporosis	3.03e-07	0.000559	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—IRS2—osteoporosis	3.03e-07	0.000559	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—LEP—osteoporosis	2.96e-07	0.000547	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—ESR1—osteoporosis	2.89e-07	0.000534	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—ESR1—osteoporosis	2.83e-07	0.000522	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—CYP19A1—osteoporosis	2.76e-07	0.000509	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—POMC—osteoporosis	2.72e-07	0.000502	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—IRS1—osteoporosis	2.7e-07	0.000499	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—IRS1—osteoporosis	2.64e-07	0.000488	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—POMC—osteoporosis	2.6e-07	0.00048	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—POMC—osteoporosis	2.54e-07	0.00047	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—IL6R—osteoporosis	2.54e-07	0.000468	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—CYP19A1—osteoporosis	2.54e-07	0.000468	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—CYP19A1—osteoporosis	2.51e-07	0.000464	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—IGF1—osteoporosis	2.5e-07	0.000462	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—IL6R—osteoporosis	2.48e-07	0.000458	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—IGF1—osteoporosis	2.45e-07	0.000452	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—ADCY5—osteoporosis	2.25e-07	0.000416	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—GPX1—osteoporosis	2.24e-07	0.000414	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—ADCY5—osteoporosis	2.07e-07	0.000382	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—MTHFR—osteoporosis	2.07e-07	0.000382	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—GPX1—osteoporosis	2.06e-07	0.000381	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—ADCY5—osteoporosis	2.05e-07	0.000379	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—GPX1—osteoporosis	2.05e-07	0.000378	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—IL6—osteoporosis	1.91e-07	0.000353	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—MTHFR—osteoporosis	1.91e-07	0.000352	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—MTHFR—osteoporosis	1.89e-07	0.000349	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—IL6—osteoporosis	1.87e-07	0.000346	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—POMC—osteoporosis	1.66e-07	0.000306	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—POMC—osteoporosis	1.52e-07	0.000281	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—POMC—osteoporosis	1.51e-07	0.000279	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—MYC—osteoporosis	1.5e-07	0.000278	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—TGFB1—osteoporosis	1.5e-07	0.000277	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—MYC—osteoporosis	1.47e-07	0.000272	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—TGFB1—osteoporosis	1.47e-07	0.000271	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—IL6—osteoporosis	1.13e-07	0.000209	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—IL6—osteoporosis	1.11e-07	0.000204	CbGpPWpGaD
